Page 31 - Coronavirus Vaccine

Latest news LIVE: Chandigarh University closed till Saturday amid protests

From Covid to all other developments, catch all the live news updates here

Data story: India records 4,858 new Covid cases; active tally at 48,027

India has added 38,466 cases in the past 7 days

Data story: India logs 5,664 new Covid cases; active tally rise to 47,922

India has added 38,829 cases in the past 7 days

Data story: India logs 6,422 new Covid cases; active tally rises to 46,389

India has so far administered 2,159,816,124 vaccine doses

Data story: India logs 5,108 new Covid cases; death toll at 528,216

India has so far administered 2,156,706,574 vaccine doses

Nasal vaccines for Covid-19: How do they work and what are their benefits?

The Drugs Controller General of India (DCGI), on Tuesday, approved Bharat Biotech's anti-covid vaccine for emergency use. It is the first such vaccine in the country

UP becomes the first state to cross 380 mn mark in Covid-19 vaccine doses

Uttar Pradesh has crossed the 38-crore mark of administering Covid-19 vaccine doses and has become the first state in India to have achieved this figure

Delhi reports 118 new Covid cases, no deaths; active tally at 591

The total number of cumulative beneficiaries vaccinated so far stands at 3,68,81,422, according to the health bulletin

Latest LIVE updates : IMD issues yellow alert for Mumbai, Thane, Sindhudurg

From coronavirus to BCCI's plea on tenure of its office bearers, catch the latest developments from across the globe here

Data story: India adds 4,369 new Covid cases; active tally at 46,347

India has added 38,087 cases in the past 7 days

European Medicines Agency clears Pfizer-BioNTech's tweaked Covid booster

The European Medicines Agency has recommended the authorisation of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunisation programs ahead of winter. The EU regulator said Monday that laboratory studies suggest the combination vaccine which targets both the original COVID-19 virus as well as the omicron subvariants BA.4 and BA.5 should trigger an effective immune response. The vaccine is expected to be as safe as the original version, but the agency will continue to track its rollout globally since the data is limited. The U.S. Food and Drug Administration gave the modified vaccine shot the green light last month. According to the World Health Organisation, the BA.5 version of omicron is responsible for most of the COVID-19 spreading globally; it made up about 87% of all virus sequences shared with the biggest public database. Earlier this month, the .

Daily Covid cases drop to 63 in Delhi, 1 death; active tally at 619

Delhi recorded one more death due to COVID-19 and 63 fresh cases of the infection with a positivity rate of 1.83 per cent on Monday, according to the data shared by the city health department. The new cases were detected from the 3,434 tests conducted the previous day, the department said in its latest bulletin. With the new cases and fatalities, Delhi's COVID-19 tally has climbed to 20,01,769 and the death toll has gone up to 26,494, according to the bulletin. On Sunday, the city logged 137 new Covid cases with a positivity rate of 1.36 per cent and two more fatalities. The national capital recorded no death due to Covid and 137 cases of the infection with a positivity rate of 1.17 per cent on Saturday. On Friday, the city saw 123 Covid cases with a positivity rate of 1.06 per cent and four fatalities. On Thursday, it reported 182 Covid cases with a positivity rate of 1.37 per cent and three fatalities. The day before, it recorded 177 cases of the viral disease with a positivity

Residents under Covid lockdowns in China complain of food shortages: Report

Authorities are scrambling to contain local outbreaks ahead of the Communist Party of China's congress in October

Data story: India logs 5,221 new Covid cases; death toll at 528,165

India has added 38,135 cases in the past 7 days

DCGI nod sought for phase-3 study of intranasal Covid vax in 5-18 age group

Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of its intranasal COVID-19 vaccine in the 5 to 18 age group. On September 6, the Drugs Controller General of India (DCGI) had approved its intranasal Covid vaccine iNCOVACC for restricted emergency use in those aged above 18 years. "Now the Hyderabad based firm has submitted an application seeking permission to conduct phase-3, multicenter study to evaluate the safety, reactogenicity and immunogenicity of iNCOVACC (BBV154) in those aged 18 to 5 years," an official source told PTI. iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candidate was evaluated in phase 1, 2 and 3 clinical trials with successful results, a release from the vaccine-maker said. BBV154 has been specifically formulated to allow intranasal delivery. "Being an intranasal vaccine, BBV154 may produce local antibodies in the up

Data story: India logs 5,076 new Covid cases; death toll at 528,150

India has added 38,824 cases in the past 7 days.

Canada approves Pfizer Covid-19 vaccine for kids under five years

Health Canada has approved Pfizer's Covid-19 vaccine to immunise children under the age of five

Delhi logs 123 fresh Covid cases, 4 deaths in a day; active tally at 788

Delhi on Friday recorded 123 fresh COVID-19 cases with a positivity rate of 1.06 per cent while four more people succumbed to the disease, according to data shared by the health department here. The new cases were detected from 11,567 tests conducted the previous day, the department said in its latest bulletin. With the fresh cases and fatalities, Delhi's infection tally increased to 20,01,432 and the death toll reached 26,491, it said. On Thursday, the city logged 182 COVID-19 cases with a positivity rate of 1.37 per cent and three fatalities. The day before, it recorded 177 COVID-19 cases with a positivity rate of 1.36 per cent, and two deaths. The government did not issue a bulletin on Monday and Tuesday. On Sunday, the national capital recorded 218 cases with a positivity rate of 1.93 per cent. A day before, the city had logged 236 cases with a positivity rate of 1.68 per cent and three deaths. The number of active Covid cases in Delhi stands at 788. As many as 585 patients a

What are nasal vaccines and how do they work?

The Drugs Controller General of India has approved the first intra-nasal Covid-19 vaccine for restricted use. A few drops in both the nostril will keep the virus at bay. Let us find out more

Two Israel-based antibodies may fight all known Covid-19 strains: Study

Scientists in Israel have isolated two antibodies from the immune system of recovered COVID-19 patients that may neutralise all known strains of SARS-CoV-2, including Omicron, with up to 95 per cent efficiency. The team at Tel Aviv University noted that targeted treatment with antibodies and their delivery to the body in high concentrations may serve as an effective substitute for vaccines, especially for at-risk populations and those with weakened immune systems. By using antibody treatment, there is a possibility that the need to provide repeated booster shots to the entire population every time a new variant emerges will be eliminated, the researchers said. The study, recently published in the journal Communications Biology, is a continuation of a preliminary research conducted in October 2020, at the height of the COVID-19 crisis. At that time, the team sequenced all the B immune system cells from the blood of people who had recovered from the original COVID-19 strain in Israel